A patient survey rated benzodiazepines and antidepressants together as helpful, leaving their separate effects unresolved.
The study received 370 survey participants, with 287 valid responses in the treatment section. Patients with motion-triggered and other-onset symptoms described strategies they had tried and their perceived helpfulness. A combined benzodiazepine/antidepressant category was reported as the most beneficial medication grouping in both subtypes.
The survey cannot isolate which drug, dose, or combination accounted for reported benefit. Treatment was not randomized, and symptom changes could reflect selection, expectations, or other care. Recruitment relied on English-language online access, and people in remission may have been less likely to participate. The findings document patient experience rather than a controlled efficacy estimate. They cannot establish that a particular benzodiazepine treats the underlying mechanism or that long-term benefits outweigh risks for all patients.
Original analysis of the supplied journal article, identified as PMC6240763.